Reply to the Correspondence: "Heterogeneity Among Plasma-Derived von Willebrand Factor Concentrates: Implications for Comparative Effectiveness Analyses"
Authors:
- 23 July 2026
- journal article
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Heterogeneity Among Plasma-Derived von Willebrand Factor Concentrates: Implications for Comparative Effectiveness AnalysesSeminars in Thrombosis and Hemostasis, 2026
- Vonicog Alfa versus Plasma-Derived von Willebrand Factor During Hospitalization: Results of an Observational Retrospective Multicenter StudySeminars in Thrombosis and Hemostasis, 2026
- Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand DiseaseJournal of Blood Medicine, 2022
- Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand diseaseBlood Advances, 2021
- Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factorBlood Reviews, 2019
- Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assayResearch and Practice in Thrombosis and Haemostasis, 2018
- Comparative Analysis and Classification of von Willebrand Factor/Factor VIII Concentrates: Impact on Treatment of Patients with von Willebrand DiseaseSeminars in Thrombosis and Hemostasis, 2006